GSK's tuberculosis vaccine shows promising results

The new vaccine, known as M72/AS01E, was tested at 11 sites in Kenya, South Africa and Zambia in adults whose blood tests showed they had latent TB. The study revealed that the vaccine could cut the number of people developing TB by half.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/335Kkkl
via IFTTT